Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


2nd Enhancing Drug Bioavailability & Solubility

21 Jan 2013 - 23 Jan 2013 - Boston, MA, USA



Bookmark and Share


Based on the successes of our inaugural Enhancing Drug Bioavailability and Solubility Conference in 2012, ExL Pharma brings together the industry’s leading formulation experts together to share and discuss emerging drug bioavailability and solubility enhancement strategies. Learn from the industry's most accomplished drug formulation and preformulation experts. Join 125+ executives from 80+ leading organizations to discuss and hear unique take-home examples, case studies and multiple formulation and preformulation strategies to assist in improving drug solubility and bioavailability, maximizing exposure, and reducing time-to-market on future drug products.


 What Will You Learn?


Rationale formulation design for poorly soluble compounds

Pharmaceutical formulation development strategies: Considerations for successful product development

Improving oral bioavailability for poorly water-soluble drug candidates 

Experimental methods for investigating and maintaining supersaturation to enhance drug bioavailability

Solubilities of crystalline drugs in polymers

Solubilization approaches for parenteral routes of administration

Product diversification and enhancement through pre-formulation technologies

Patent opportunities for solubility solutions 

Enhancing API bioavailability via nanotechnology for drug delivery  

Application of nanotechnology for the enhancement of skin permeability for poorly soluble compounds

Improving oral modified release dosage forms 



Further information
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!